Question 1

What is Simulations Plus (United States) known for?

Accepted Answer

In research, Simulations Plus (United States) stands highest in Physical Sciences (#11,045 of 17,446 worldwide), over all time.

Question 2

How does Simulations Plus (United States) rank in research?

Accepted Answer

Simulations Plus (United States) ranks #21,341 of 22,385 institutions worldwide on research quality in 2022-now (#18,872 all time), and #3,153 of 3,332 in the United States.

Question 3

Who are the top researchers at Simulations Plus (United States)?

Accepted Answer

Ranked on the quality score, Marvin Waldman, Robert D. Clark and Michael B. Bolger lead among researchers whose main affiliation is Simulations Plus (United States).

Question 4

What are the most cited papers from Simulations Plus (United States)?

Accepted Answer

The most cited paper from Simulations Plus (United States) is "COMPASS: An ab Initio Force-Field Optimized for Condensed-Phase ApplicationsOverview with Details on Alkane and Benzene Compounds" (Huai Sun, 1998), with 6,007 citations. Next come "The COMPASS force field: parameterization and validation for phosphazenes" (1,560) and "Predicting the impact of physiological and biochemical processes on oral drug bioavailability" (656).

Question 5

Which research topics does Simulations Plus (United States) publish most on?

Accepted Answer

By volume in 2022-now: Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms and Antibiotics Pharmacokinetics and Efficacy.

Question 6

Which keywords describe research at Simulations Plus (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Pharmacokinetics, Genetic Variation, Medicinal Chemistry, Cytochrome P450, Pharmacogenetics, Molecular Docking, Drug Target Identification and Virtual Screening.

Question 7

Which fields of science does Simulations Plus (United States) work in?

Accepted Answer

In 2022-now, 43% of research at Simulations Plus (United States) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (42%), Pharmacology, Toxicology and Pharmaceutics (12%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.8× the world's share of Life Sciences.

Question 8

Is Simulations Plus (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 128% higher than in 2018-2021.